PUREOptics provides significantly improved imaging efficiency from photon generation to detection. An optimized beam spectrum combined with a more efficient detector result in a better balance between image quality and dose.
Patient specific beam shaping filters provide an optimized X-ray spectrum and more homogenous distribution, improving low contrast detectability by up to:
19% improved LCD at equivalent dose—brain*
22% improved LCD at equivalent dose—body*
31% dose reduction at equivalent low contrast detectability*
*A non-prewhitening model observer study was conducted comparing Aquilion Prime SP to the Aquilion PRIME. Dose reduction values were established by comparing low contrast detectability under baseline conditions for abdominal and brain examination.Based on the detectability index performance metric, a measure of signal to noise that takes into account the magnitude and texture of both the signal and the noise for a given LCD task.
In CTA examinations SURESubtraction (SCT) has the ability to remove bone, calcium and stents from data sets allowing clinicians an unobstructed view of the arteries. Moreover, Iodine Mapping SCT enables the assessment of the distribution of contrast media within the body to visualize local perfusion.
AIDR 3D has been developed as the next step in the evolution of noise reduction technology. This iterative algorithm removes noise in the raw and image data space, by analyzing and processing the data repeatedly.
Due to medical device regulatory reasons, not all products/service displayed on this Canon Medical Systems Korea webpage are available in all countries, regions or markets. Future availability of the products/service cannot also be guaranteed. Please contact your local Canon Medical Systems representative for further details.